One-Electron Oxidation of Gemcitabine and Analogs: Mechanism of Formation of C3鈥?and C2鈥?Sugar Radicals
详细信息    查看全文
文摘
Gemcitabine is a modified cytidine analog having two fluorine atoms at the 2鈥?position of the ribose ring. It has been proposed that gemcitabine inhibits RNR activity by producing a C3鈥测€?intermediate via direct H3鈥?atom abstraction followed by loss of HF to yield a C2鈥测€?with 3鈥?keto moiety. Direct detection of C3鈥测€?and C2鈥测€?during RNR inactivation by gemcitabine still remains elusive. To test the influence of 2鈥? substitution on radical site formation, electron spin resonance (ESR) studies are carried out on one-electron oxidized gemcitabine and other 2鈥?modified analogs, i.e., 2鈥?deoxy-2鈥?fluoro-2鈥?C-methylcytidine (MeFdC) and 2鈥?fluoro-2鈥?deoxycytidine (2鈥?FdC). ESR line components from two anisotropic 尾-2鈥?F-atom hyperfine couplings identify the C3鈥测€?formation in one-electron oxidized gemcitabine, but no further reaction to C2鈥测€?is found. One-electron oxidized 2鈥?FdC is unreactive toward C3鈥测€?or C2鈥测€?formation. In one-electron oxidized MeFdC, ESR studies show C2鈥测€?production presumably from a very unstable C3鈥测€?precursor. The experimentally observed hyperfine couplings for C2鈥测€?and C3鈥测€?match well with the theoretically predicted ones. C3鈥测€?to C2鈥测€?conversion in one-electron oxidized gemcitabine and MeFdC has theoretically been modeled by first considering the C3鈥测€?and H3O+ formation via H3鈥?proton deprotonation and the subsequent C2鈥测€?formation via HF loss induced by this proximate H3O+. Theoretical calculations show that in gemcitabine, C3鈥测€?to C2鈥测€?conversion in the presence of a proximate H3O+ has a barrier in agreement with the experimentally observed lack of C3鈥测€?to C2鈥测€?conversion. In contrast, in MeFdC, the loss of HF from C3鈥测€?in the presence of a proximate H3O+ is barrierless resulting in C2鈥测€?formation which agrees with the experimentally observed rapid C2鈥测€?formation.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700